Expert Opinion on Therapeutic Patents

Terrorising patents
pp. 329-330(2)
Author: Goldberg R.

Prodrug strategies in nasal drug delivery
pp. 331-340(10)
Authors: Pezron I.; Mitra A.K.; Duvvuri S.; Tirucherai G.S.

Modulation of Th1 and Th2 responses for immunotherapy
pp. 341-367(27)
Author: Dumont F.J.

Viral approaches to cancer gene therapy
pp. 369-378(10)
Authors: Green N.; Hale S.

Antisense strategies and non-viral gene therapy for cancer
pp. 379-391(13)
Authors: Bremner K.H.; Read M.L.

Inhibitors of protein-protein interactions
pp. 393-400(8)
Authors: Gadek T.R.; Ockey D.A.

Non-cancer therapeutic antibodies
pp. 401-417(17)
Authors: Linardou H.; Murray S.

Recent developments of cathepsin inhibitors and their selectivity
pp. 419-432(14)
Authors: Kang K.; Kim W.

Drug conjugates with albumin and transferrin
pp. 433-439(7)
Author: Kratz F.

Recent developments in the treatment and prevention of respiratory syncytial virus infection
pp. 441-449(9)
Author: Krilov L.R.

Antagonistic selective binding agents of osteoprotegerin binding protein
pp. 469-470(2)